Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Danish Dermatologic Development (DDD), which later rebranded as Ellipse A/S, was a pioneering medical technology company specializing in light-based solutions for dermatology and aesthetics. Founded in 1997 and headquartered in Denmark, the company became a global leader in the development of Intense Pulsed Light (IPL) and laser systems. Their proprietary I2PL technology set industry standards for safety and clinical efficacy, particularly in treating vascular and pigmented lesions as well as permanent hair removal. The company's flagship platforms, such as the Nordlys and Sirius systems, are widely utilized by dermatologists and plastic surgeons worldwide. In 2018, the company was acquired by Syneron Candela, integrating its advanced Danish engineering into one of the world's largest aesthetic device portfolios.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Danish Dermatologic Development.